Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $572.60M in the quarter ending March 31, 2025, with 11.12% growth. This brings the company's revenue in the last twelve months to $2.41B, up 21.73% year-over-year. In the year 2024, Neurocrine Biosciences had annual revenue of $2.36B with 24.81% growth.

• Revenue (ttm): $2.41B
• Revenue Growth: +21.73%
• P/S Ratio: 5.12
• Revenue / Employee: $1,340,333
• Employees: 1,800
• Market Cap: 12.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.36B	468.20M	24.81%
Dec 31, 2023	1.89B	398.40M	26.76%
Dec 31, 2022	1.49B	355.20M	31.34%
Dec 31, 2021	1.13B	87.60M	8.38%
Dec 31, 2020	1.05B	257.80M	32.71%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.